Introducing NMD4C Clinical Trial Concierge Bonnie Wooten
The NMD4C Clinical Trial working group’s activities strengthen and support the coordination and communication of neuromuscular clinical trials in Canada to optimize access for all stakeholders to timely and accurate information.
To facilitate the network’s Clinical Trial Coordination activities and to meet this demand, the NMD4C is excited to announce the hiring of Bonnie Wooten, who has joined the team in her role as the Clinical Trial Concierge. In her role, Bonnie will work with all stakeholders including clinicians, families, and industry.
Bonnie has already begun to collect information on the current landscape of neuromuscular clinical trials in Canada; stay tuned for more information to come in the coming months.
Read next...
Call for Applications: 2026 NMD4C Collaborative Research Training Awards
Application Deadline: June 15, 2026.
We are excited to share that the second cycle of our Collaborative Research Training Award program is now open for applications!
Congratulations to our NMD4C Investigators on Receiving a 2025 Defeat Duchenne Canada Research Grant!
NMD4C is proud to celebrate two of our esteemed Investigators, Dr. James Dowling and Dr. Laura McAdam, who have been awarded research grants through the 2026 Defeat Duchenne Canada funding program!
2026 NMD4C Application & Nomination Deadlines
As we start the new year, three important NMD4C opportunities are approaching their deadlines. Members are invited to nominate a researcher or publication for the Annual NMD4C Awards, apply to join the Basic Science Trainee Committee (BSTC), and apply to attend the 2026 NMD4C Basic Research Summer School, taking place June 8–10 under the leadership of Dr. Mireille Khacho. Registration for the summer school is free, with travel and accommodations covered for non‑local trainees.